Shanghai Helioson Pharmaceutical Co., Ltd. was founded in October 2021 and was located in Wisdom Plaza of Pujiang Town, Minhang District, Shanghai, with a registered capital of 125.71 million yuan. As a patient-oriented and clinical-value guided company, Helioson is mainly engaged in the therapeutic areas including hematoma and solid tumor based on the in-deep research and investigation of disease mechanism. Bulit with internationalization and differentiation mindset, we aim to develop innovative fist-in-class or best-in-class chemical drugs with great commercial value in global marketing.